Sorry, you need to enable JavaScript to visit this website.

XALKORI® (crizotinib) Indications and Usage

1 INDICATIONS AND USAGE

XALKORI is indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test [see Dosage and Administration (2.1)].

Prescribing information (PDF)

Open Prescribing information
Information for Patients

Search

Find medical information documents that include XALKORI® and:

What's New

No Current Announcements.

Other Resources

Xalkori Website for Healthcare Professionals
 
Pfizer RxPathways – find information on prescription assistance programs for eligible patients
 
Pfizer Oncology together
 
Pfizer Corporate Site
 
Pfizer News Channel on You Tube
 

Therapeutic Area

Oncology
Oncology

Contact Pfizer Medical

Report an Adverse Event
1-800-438-1985

Meet Our Team

Renee Maria Johnson, PharmD, MPH, BCPS
Sharone Keane, PharmD, MSEd

Search

Please enter your search term(s) for XALKORI®

Other Resources

Xalkori Website for Healthcare Professionals
 
Pfizer RxPathways – find information on prescription assistance programs for eligible patients
 
Pfizer Oncology together
 
Pfizer Corporate Site
 
Pfizer News Channel on You Tube
 

Contact Pfizer

Need to report an Adverse Event, Side Effect or Product Quality Concern?

Contact Pfizer Safety to report an adverse event, side effect or concern about the quality of a Pfizer product: (800) 438-1985

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns at 1-800-FDA-1088 or www.fda.gov/MedWatch

Have a Medical Question on a Pfizer Prescription Medicine?
Contact Pfizer Medical Information to speak with a professional regarding your medical question on a Pfizer prescription product: (800) 438-1985
Have a Question about Pfizer Clinical Trials?
If you are looking for information about Pfizer studies currently recruiting new patients in your area, you can begin your search on our website. For questions about a Pfizer Clinical Trial, call (800) 718-1021 or email [email protected]
Need Information on Pfizer’s Patient Assistance Programs?

Pfizer RxPathways® connects eligible patients, regardless of their insurance status, to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. For more information, please call (844) 989-7284 or visit www.PfizerRxPathways.com.

Eligible patients can register for valuable savings offers for nearly 40 brand name medications. Visit www.MyPfizerBrands.com for more information.